Radiation Treatment Plan Evaluation Learning Tool Pilot Project

NCT06115811 | Not Yet Recruiting

• 1 other identifier: 23-021
• Study Type: interventional
• Target: 20
• Locations: 1 country
• Sites: 1

Brief Summary

This study involves both the development of a novel learning tool, the Radiation Treatment Plan Evaluation Learning Module, as well as a pilot program to validate this tool as an effective resource to teach treatment plan review and optimization to radiation oncology residents.

Conditions

Radiation Oncology

Keywords

Radiation Oncology; Education

Outcome Measures

Primary Outcomes (1)

• Objective Examination Score

  Analyzed with a paired samples t-test.

  Up to 8 weeks

Secondary Outcomes (2)

• Oncology Resident Confidence Rate

  Week 1 - 8

• Oncology Resident Perceived Competence Rate

  Week 1 - 8

Study Arms (1)

Radiation Treatment Plan Evaluation Learning Module

EXPERIMENTAL

Radiation oncology resident physicians will complete study procedures as below: * Initial survey and pre-module examination. * Learning module. * Post-module survey and examination.

Behavioral: Radiation Treatment Plan Evaluation Learning Tool

Interventions

Radiation Treatment Plan Evaluation Learning Tool BEHAVIORAL

Web-based program comprised of a systematic, oncology treatment plan review system and learning modules. The case bank of radiation treatments plans is accessible via econtour.org.

Radiation Treatment Plan Evaluation Learning Module

Eligibility Criteria

• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• The pilot program will be open to radiation oncology resident physicians that are in their PGY-2, PGY-3, or PGY-4 year.
• All residents must have completed a breast cancer-specific radiation oncology rotation at least 3 months prior to enrollment in the pilot program in order to be eligible.

You may not qualify if:

• The study will not include any special populations.

Sponsors & Collaborators

• Massachusetts General Hospital: lead

Study Sites (1)

Massachusetts General Hospital Cancer Center

Boston, Massachusetts, 02215, United States

Location

Study Officials

• Rachel Jimenez, MD

  Massachusetts General Hospital

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Rachel Jimenez, MD

CONTACT

617-726-8651; RBJIMENEZ@PARTNERS.ORG

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: October 30, 2023
• First Posted: November 3, 2023
• Study Start: January 15, 2026
• Primary Completion (Estimated): November 1, 2026
• Study Completion (Estimated): December 1, 2026
• Last Updated: November 13, 2025

Record last verified: 2025-11

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL, SAP
• Time Frame: Data can be shared no earlier than 1 year following the date of publication
• Access Criteria: Contact the Partners Innovations team at http://www.partners.org/innovation

Locations

US (1)